Francesca Capotosti

Dr. Capotosti has been at AC Immune since 2013. Having joined as a Research scientist, she was appointed Team Leader working primarily on small molecules targeting Tau as therapeutic and diagnostic agents. Most recently, she was Associate Vice President and Global Project Leader working on small molecule therapeutic programs targeting Tau and a-syn.   She also played a key role in the a-syn PET tracer program, which delivered the first tracer capable of detecting a-syn pathology in patients. She joined AC Immune following postdoctoral studies at the École Polytechnique Fédérale de Lausanne (EPFL). In 2010 she obtained a PhD in Life Sciences from the University of Lausanne.